BMS 6072 (Glucovance 1.25 mg / 250 mg)
Generic Name: glyburide/metformin
Pill imprint BMS 6072 has been identified as Glucovance 1.25 mg / 250 mg.
Glucovance is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. There is no proven risk in humans during pregnancy. Glucovance 1.25 mg / 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for BMS 6072 (Glucovance 1.25 mg / 250 mg)
- Generic Name:
- 1.25 mg / 250 mg
- 13.00 mm
- Elliptical / Oval
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Bristol-Myers Squibb
- National Drug Code (NDC):
- Inactive Ingredients:
- microcrystalline cellulose
|NDC Code||Manufacturer / Repackager|
|54868-4906||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about Glucovance (glyburide / metformin)
Compare with other treatments for:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...